Vitamin D increases programmed death receptor-1 expression in Crohn’s diseaseMia Bendix, Jørgen Agnholt, Søren Peter Jørgensen et al.|Oncotarget|2017Cited by 31
Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-UpMia Bendix, Jørgen Agnholt, Jens Frederik Dahlerup et al.|Nutrients|2021Cited by 27
Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's diseaseMia Bendix, Jørgen Agnholt, Anders Dige et al.|Clinical & Experimental Immunology|2015Cited by 19
Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn’s Disease Patients Treated with High-Dose Vitamin D Alone or Combined with InfliximabMia Bendix, Jørgen Agnholt, Anders Dige et al.|Nutrients|2020Cited by 18
Gal-3 blocks the binding between PD-1 and pembrolizumabStinne Ravn Greisen, Bent Deleuran, Mia Bendix et al.|Journal for ImmunoTherapy of Cancer|2024Cited by 11